Healthy Systems

Solutions that create positive change in Food, Agriculture and Human Health.

 

Healthy Systems

Impact Results 2024

4 -> 5
Technology Readiness Level (TRL 5,6,7)

4 -> 8
Technology Readiness Level (TRL 5,6,7)

Environmental footprint in CO2 equivalent emissions/kg *

* Recent investment with no data yet and or no binary targets

5.432 [98*]
People supplied with medication

33.036 [2.676*]
Reductions in surgical complications

2.024.501 [163.985*]
Number of skin assessments

91.520 [1.647*]
Informed health decisions

85.232 [4.176*]
Unique mental health user sessions

% cost reduction in cultured meat*

* Recent investment with no data yet and or no binary targets

Regulatory approval of the product*

Tonnes of meat analogues sold*

Filed a dossier for regulaFiled a dossier for regulatory approval (US, EU, LatAm)*

Proven efficacy and non-toxicity in commercial trial*

#kg of cultured meat produced*

* Recent investment with no data yet and or no binary targets
*To enhance transparency, Rubio now reports on attribution alongside our total impact reporting. Attribution reflects the portion of impact linked to our role as investors and is calculated using prorating on equity—allocating a company’s impact proportionally to our percentage ownership as of 31/12/2024.
Impact Case NoPalm Ingredients

Impact Case: NoPalm Ingredients

In this impact case of NoPalm Ingredients, you can read all about how NoPalm is revolutionizing oil production with its fermentation-based technology, providing a sustainable and scalable alternative to palm oil while drastically reducing deforestation, land use, and carbon emissions.

Our Healthy Systems Investments

“Despite economic and political uncertainty, our portfolio raised €100M+ in follow-on funding. Early-stage breakthroughs thrive, late-stage funding matures, and non-dilutive capital grows. Market cycles shift, but the drive for a resilient society is forever.”